| Shareholder | |||
|---|---|---|---|
| Tianjin Fuhuade Technology Development Co., Ltd. 天津富华德科技开发有限公司 | 37.23% | 191.60M | |
| Yan Kaijing | 37.23% | 191.60M | |
| Yan Xijun | 37.23% | 191.60M | |
| Li Yunhui | 37.23% | 191.60M | |
| Wu Naifeng | 37.23% | 191.60M | |
| 嘉泽宏业(天津)科技有限公司 | 30.34% | 187.36M | |
| Cao Fei | 30.34% | 187.36M | |
| Cao Longxiang | 30.34% | 187.36M | |
| TAN ZhengExecutive Director | 26.60% | 164.29M | |
| China Resources Company Limited | 23.99% | 148.14M | |
| 華潤三九醫藥股份有限公司China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 15.66% | 96.68M | |
| Tan Xiaoyang | 9.68% | 59.79M | |
| Tan Yueyue | 9.68% | 59.79M | |
| WANG MINHUI | 8.22% | 50.76M | |
| ZHANG JUNZHENG | 8.22% | 50.76M | |
| Greater Bay Area Homeland Investments Limited | 6.63% | 33.14M | |
| JUNG Hyun Chul | 5.99% | 30.82M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of IMMUNOTECH-B (06978) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

